Home Journals Subjects About My LA Reviewers Authors News Submit
Username: Password:
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement
 
 
 
 
 
 

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum

Authors: Daniel Gilbert Weber, Georg Johnen, Dirk Taeger, Anne Weber, Isabelle Mercedes Gross, Beate Pesch, Thomas Kraus, Thomas Brüning and Monika Gube
Publication Date: 28 Jan 2010
Biomarker Insights 2010:5 1-8

Daniel Gilbert Weber1, Georg Johnen1, Dirk Taeger1, Anne Weber1, Isabelle Mercedes Gross1, Beate Pesch1, Thomas Kraus2, Thomas Brüning1 and Monika Gube2

1BGFA—Research Institute of Occupational Medicine, German Social Accident Insurance, Ruhr-University Bochum, Bochum, Germany. 2Institute for Occupational and Social Medicine, RWTH Aachen University, Aachen, Germany.  

Abstract

The purpose of this analysis was to evaluate if serum levels of potential tumor markers for the diagnosis of malignant mesothelioma and lung cancer are affected by confounding factors in a surveillance cohort of workers formerly exposed to asbestos. SMRP, CA125, and CYFRA21-1 concentrations were determined in about 1,700 serum samples from 627 workers formerly exposed to asbestos. The impact of factors that could modify the concentrations of the tumor markers was examined with linear mixed models. SMRP values increased with age 1.02-fold (95% CI 1.01–1.03) and serum creatinine concentration 1.32-fold (95% CI 1.20–1.45). Levels differed by study centers and were higher after 40 years of asbestos exposure. CA125 levels increased with longer storage of the samples. CYFRA21-1 values correlated with age 1.02-fold (95% CI 1.01–1.02), serum creatinine 1.21-fold (95% CI 1.14–1.30) and varied by study centers due to differences in sample handling. Tumor marker concentrations are influenced by subject-related factors, sample handling, and storage. These factors need to be taken into account in screening routine.

Categories: Cancer , Biomarkers



Send to EndnoteView on Pubmed